Related Experiment Video
Updated: Mar 29, 2026

08:23
Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection
Published on: May 9, 2022
5.2K
Beyond Resection: Surgery as an Evolutionary Bottleneck Shaping Tumor Evolution and Treatment Response in Diffuse
Paolo Tini1, Flavio Donnini1, Giovanni Rubino1
1Unit of Radiation Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Cancers
|March 28, 2026
Summary
Surgery for brain tumors (CNS tumors) triggers biological changes, promoting tumor regrowth and recurrence. Understanding this biological impact is key to improving long-term cancer control.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Surgical Oncology
Background:
- Surgical resection is a primary treatment for central nervous system (CNS) tumors, especially diffuse gliomas.
- Traditional evaluation focuses on quantitative metrics like extent of resection and survival.
- Despite complete resection, malignant CNS tumors frequently recur, indicating incomplete understanding of post-surgical dynamics.
Purpose of the Study:
- To propose a framework redefining surgery as a biological driver in CNS tumor progression.
- To synthesize evidence on how surgical trauma impacts the tumor microenvironment and evolution.
- To challenge anatomy-based surgical completeness paradigms with a biological perspective.
Main Methods:
- Literature review synthesizing evidence on surgery-induced biological changes.
- Conceptual framework development reframing surgery's role.
- Analysis of molecular and evolutionary perspectives on tumor recurrence.
Main Results:
- Surgical trauma induces inflammation, hypoxia, and immune modulation, reprogramming the tumor microenvironment.
- These changes promote the survival of adaptive, invasive tumor cell subpopulations.
- Surgery acts as a selective bottleneck, driving clonal selection and molecular divergence.
- Discrepancy between anatomical and biological margins explains recurrence patterns.
Conclusions:
- Surgery is a biologically active event influencing CNS tumor progression and recurrence.
- Surgery-induced changes impact the effectiveness of adjuvant therapies like radiotherapy and systemic treatments.
- Future neuro-oncology requires integrating biological insights into surgical planning and postoperative care for improved disease control.

